Corbus Pharmaceuticals Holdings, Inc.
CRBP
$10.03
$0.141.42%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.03% | -78.15% | 30.86% | -37.87% | -44.91% |
| Total Depreciation and Amortization | -34.57% | -39.55% | -11.84% | 1.33% | -1.32% |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | -42.42% | -29.79% |
| Total Other Non-Cash Items | -39.84% | 47.01% | -38.82% | 477.82% | 264.10% |
| Change in Net Operating Assets | 112.20% | 60.78% | -25.74% | -515.57% | 132.84% |
| Cash from Operations | -1.08% | -50.07% | 21.52% | -55.90% | -12.25% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.10% | 107.59% | 156.82% | 6.53% | 83.27% |
| Cash from Investing | -2.10% | 107.59% | 156.82% | 6.53% | 83.27% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -380.89% | 2.20% |
| Issuance of Common Stock | -- | -- | -- | -3.46% | -65.81% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -100.05% | -28.37% | -67.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -32.78% | 176.49% | 47.81% | -144.49% | 2,428.50% |